Laboratory Corporation of America Holdings (LH) 138.37

New Post Public Reply Private Reply Replies (0) Message Board

Sep 6, 2016 at 11:16 PM

Laboratory Corporation of America Holdings (LH) 138.37 $LH

LabCorp is Scheduled to Present at the Morgan Stanley Global Healthcare Conference
BusinessWire - Tue Sep 06, 7:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced it will participate at the Morgan Stanley Global Healthcare Conference. LabCorp's presentation is planned for Monday, September 12, 2016 at 10:30 AM (ET).
LH: 138.37 (+0.66), MS: 31.75 (-0.14)

23.9% Return Seen to Date on SmarTrend Laboratory Corp of America Holdings Call (LH)
Comtex SmarTrend(R) - Thu Sep 01, 1:07AM CDT
SmarTrend identified an Uptrend for Laboratory Corp of America Holdings (NYSE:LH) on February 22nd, 2016 at $110.54. In approximately 6 months, Laboratory Corp of America Holdings has returned 23.87% as of today's recent price of $136.93.
LH: 138.37 (+0.66)

LabCorp's Takeover of Sequenom Wins Antitrust Clearance
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 4:26PM CDT
LabCorp (LH) recently got the antitrust review clearance for its previously announced acquisition of Sequenom.
DSCI: 4.59 (-0.13), SQNM: 2.39 (-0.01), ALGN: 95.26 (-0.52), LH: 138.37 (+0.66)

Research Report Initiation on These Healthcare Stocks -- VWR Corp., DexCom, Laboratory Corp. of America, and PerkinElmer
PR Newswire - Thu Aug 25, 7:00AM CDT
Operators in the Medical Laboratories and Research segment provide healthcare practitioners with information concerning the onset, severity, and cause of patients' ailments and illnesses. Equities under evaluation on Stock-Callers.com are: VWR Corp. (NASDAQ: VWR), DexCom Inc. (NASDAQ: DXCM), Laboratory Corp. of America Holdings (NYSE: LH), and PerkinElmer Inc. (NYSE: PKI). Learn more about these stocks by downloading their free report at:
DXCM: 94.28 (+2.19), VWR: 26.74 (-1.05), LH: 138.37 (+0.66), PKI: 53.77 (+0.31)

Laboratory Corp of America Holdings Shares Up 24.7% Since SmarTrend's Buy Recommendation (LH)
Comtex SmarTrend(R) - Wed Aug 24, 1:32PM CDT
SmarTrend identified an Uptrend for Laboratory Corp of America Holdings (NYSE:LH) on February 22nd, 2016 at $110.54. In approximately 6 months, Laboratory Corp of America Holdings has returned 24.72% as of today's recent price of $137.87.
LH: 138.37 (+0.66)

LabCorp's Acquisition of Sequenom Clears Antitrust Review
BusinessWire - Tue Aug 23, 7:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, applicable to the acquisition of Sequenom, Inc. ("Sequenom"

by LabCorp has expired. As previously announced, LabCorp and Savoy Acquisition Corp., its direct wholly owned subsidiary ("Purchaser"

, commenced a tender offer on August 9, 2016, for all of the outstanding shares of common stock of Sequenom, including the associated preferred stock purchase rights, for $2.40 net to the seller in cash, without interest thereon and subject to applicable withholding taxes. The expiration of the waiting period under the HSR Act satisfies one of the conditions necessary for the consummation of the pending acquisition. The tender offer and any withdrawal rights are scheduled to expire at 12:01 a.m., Eastern Time, on Wednesday, September 7, 2016, unless the tender offer is extended. Consummation of the tender offer remains subject to other customary closing conditions, including satisfaction of the minimum tender condition under the agreement and plan of merger entered into by LabCorp, Purchaser and Sequenom on July 26, 2016.
SQNM: 2.39 (-0.01), LH: 138.37 (+0.66)

LabCorp Q2 Results Strong, Sequenom Buyout Raises Hope
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 10:16AM CDT
On Aug 18, 2016, we issued an updated research report on LabCorp (LH), a leading independent clinical laboratory company.
DSCI: 4.59 (-0.13), ALGN: 95.26 (-0.52), LH: 138.37 (+0.66), ATRS: 1.31 (+0.05)

Uptrend Call Working As Laboratory Corp of America Holdings Stock Rises 25.6% (LH)
Comtex SmarTrend(R) - Wed Aug 17, 12:57AM CDT
SmarTrend identified an Uptrend for Laboratory Corp of America Holdings (NYSE:LH) on February 22nd, 2016 at $110.54. In approximately 6 months, Laboratory Corp of America Holdings has returned 25.64% as of today's recent price of $138.89.
LH: 138.37 (+0.66)

Laboratory Corp of America Holdings Has Returned 26.6% Since SmarTrend Recommendation (LH)
Comtex SmarTrend(R) - Tue Aug 09, 1:33PM CDT
SmarTrend identified an Uptrend for Laboratory Corp of America Holdings (NYSE:LH) on February 22nd, 2016 at $110.54. In approximately 6 months, Laboratory Corp of America Holdings has returned 26.65% as of today's recent price of $140.00.
LH: 138.37 (+0.66)

Zacks.com featured highlights: Laboratory Corp. of America Holdings, Synopsys, Intel, VMware and Euronet Worldwide
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 8:30AM CDT
Zacks.com featured highlights: Laboratory Corp. of America Holdings, Synopsys, Intel, VMware and Euronet Worldwide
VMW: 73.39 (-0.39), LH: 138.37 (+0.66), EEFT: 78.79 (-0.02), SNPS: 59.80 (+0.13), INTC: 36.57 (+0.49)

LabCorp Commences Cash Tender Offer for All Outstanding Shares of Sequenom, Inc.
BusinessWire - Tue Aug 09, 7:00AM CDT
Laboratory Corporation of America(R) Holdings (NYSE: LH) today announced the commencement of its cash tender offer for all outstanding shares of the common stock of Sequenom, Inc. (NASDAQ: SQNM) for $2.40 per share. The tender offer is being made by Savoy Acquisition Corp., a wholly owned subsidiary of LabCorp, pursuant to an offer to purchase, dated August 9, 2016. LabCorp and Sequenom previously announced that they entered into an agreement and plan of merger, dated as of July 26, 2016, for LabCorp to acquire Sequenom.
SQNM: 2.39 (-0.01), LH: 138.37 (+0.66)

5 Stocks with Incredible Sales Growth to Buy Now
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 9:56AM CDT
A careful selection of stocks considering certain factors should help investors to not only build wealth but beat the market as well - Laboratory Corp. of America Holdings (LH), Synopsys Inc. (SNPS), Intel Corporation (INTC) in focus.
VMW: 73.39 (-0.39), LH: 138.37 (+0.66), EEFT: 78.79 (-0.02), SNPS: 59.80 (+0.13), INTC: 36.57 (+0.49)

LabCorp Announces the Availability of the CDC Zika MAC-ELISA Test
BusinessWire - Tue Aug 02, 11:45AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced the nationwide availability of testing for Zika virus using the Zika Immunoglobulin M (IgM) Antibody Capture Enzyme-Linked Immunosorbent Assay (Zika MAC-ELISA) developed by the Centers for Disease Control and Prevention (CDC). The test received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), initially on February 26, 2016, and reissued on June 29, 2016, for the qualitative detection of Zika virus IgM antibodies in serum or cerebrospinal fluid (collected alongside a patient-matched serum specimen), and is being made available for the first time to commercial laboratories. It is intended to be used in the diagnosis of Zika virus infection in individuals meeting clinical and/or epidemiological criteria established by CDC for Zika virus infection risk.
LH: 138.37 (+0.66)

SEQUENOM SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Sequenom, Inc. (SQNM) Over the Proposed Sale of the Company to Laboratory Corporation of America Holdings
PR Newswire - Mon Aug 01, 4:01PM CDT
Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Sequenom, Inc. ("Sequenom" or the "Company"

(NASDAQ: SQNM) for potential breaches of fiduciary duties in connection with the sale of the Company to Laboratory Corporation of America Holdings for approximately $371 million.
SQNM: 2.39 (-0.01), LH: 138.37 (+0.66)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of The Board of Directors of Sequenom, Inc. -SQNM
PR Newswire - Wed Jul 27, 8:36PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Sequenom, Inc. ("Sequenom" or "the Company"

(Nasdaq- SQNM-News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Laboratory Corporation of America Holdings ("Lab Corp."

.
SQNM: 2.39 (-0.01), LH: 138.37 (+0.66)

LabCorp (LH) Tops Q2 Earnings, View Up, to Buy Sequenom
Zacks Equity Research - Zacks Investment Research - Wed Jul 27, 12:16PM CDT
LabCorp (LH) reported a solid second quarter 2016 with adjusted earnings per share (EPS) of $2.31, up 10.5% from the year-ago quarter.
SQNM: 2.39 (-0.01), BCR: 222.04 (+0.83), LH: 138.37 (+0.66), COO: 188.30 (+2.38)

LabCorp Sees Balanced Growth; Covance Synergy on Track
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 6:00AM CDT
On Jun 20, 2016, we issued an updated research report on Laboratory Corporation of America Holdings (LH).
BCR: 222.04 (+0.83), LH: 138.37 (+0.66), HSIC: 164.31 (+0.02), COO: 188.30 (+2.38)

Laboratory Corp of America Holdings Set to Possibly Pullback After Yesterday's Rally of 2.15%
Comtex SmarTrend(R) - Mon Jun 20, 4:07PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $126.95 to a high of $129.15. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $128.43 on volume of 847,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 138.37 (+0.66)

After Yesterday's Rally of 2.15% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jun 20, 4:05PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $126.95 to a high of $129.15. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $128.43 on volume of 847,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
LH: 138.37 (+0.66)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...